Text Modules


Share

Program Content

Activities

  • AEs With TROP2 ADCs
    Identification and Management of Adverse Events With TROP-2–Targeted ADCs
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 04, 2024

    Expires: April 03, 2025

  • AEs With TROP2 ADCs
    Identification and Management of AEs With TROP-2–Targeted ADCs
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 04, 2024

    Expires: April 03, 2025

  • TROP-2 in NSCLC
    TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 25, 2024

    Expires: April 24, 2025

  • TROP-2 in NSCLC
    TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 25, 2024

    Expires: April 24, 2025

Faculty

cover img faculity

Narjust Florez, MD

Associate Director of The Cancer Care Equity Program
Thoracic Medical Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Associate Editor, JAMA Oncology
Boston, Massachusetts

cover img faculity

Matthew Gubens, MD, MS, FASCO

Professor of Medicine
Medical Director, Thoracic Medical Oncology
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.